These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 16102886)

  • 21. Plasminogen activator inhibitor activity, 4G5G polymorphism of the plasminogen activator inhibitor 1 gene, and first-trimester miscarriage in women with polycystic ovary syndrome.
    Glueck CJ; Sieve L; Zhu B; Wang P
    Metabolism; 2006 Mar; 55(3):345-52. PubMed ID: 16483878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with HELLP syndrome.
    Muetze S; Eggermann T; Leeners B; Birke C; Kuse S; Ortlepp JR; Rudnik-Schoeneborn S; Zerres K; Rath W
    J Thromb Thrombolysis; 2009 Feb; 27(2):141-5. PubMed ID: 18058192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Promoter (4G/5G) plasminogen activator inhibitor-1 genotype and plasminogen activator inhibitor-1 levels in blacks, Hispanics, and non-Hispanic whites: the Insulin Resistance Atherosclerosis Study.
    Festa A; D'Agostino R; Rich SS; Jenny NS; Tracy RP; Haffner SM
    Circulation; 2003 May; 107(19):2422-7. PubMed ID: 12719278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome.
    Walch K; Grimm C; Zeillinger R; Huber JC; Nagele F; Hefler LA
    Fertil Steril; 2004 Jun; 81(6):1638-41. PubMed ID: 15193488
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic polymorphisms associated with steroids metabolism and insulin action in polycystic ovary syndrome.
    Ramos Cirilo PD; Rosa FE; Moreira Ferraz MF; Rainho CA; Pontes A; Rogatto SR
    Gynecol Endocrinol; 2012 Mar; 28(3):190-4. PubMed ID: 21824047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease.
    Espino A; Villagrán A; Vollrath V; Hanckes P; Salas R; Farah A; Solís N; Pizarro M; Escalona A; Boza C; Pérez G; Carrasco G; Padilla O; Miquel JF; Nervi F; Chavez-Tapia NC; Arab JP; Alvarez-Lobos M; Arrese M; Riquelme A
    Ann Hepatol; 2011; 10(4):493-501. PubMed ID: 21911891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The -675 4G/5G polymorphism in the PAI-1 gene may not contribute to the risk of PCOS.
    Zhang TT; Yuan L; Yang YM; Ren Y
    Eur Rev Med Pharmacol Sci; 2014 Aug; 18(16):2326-31. PubMed ID: 25219833
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The 4G/4G plasminogen activator inhibitor-1 genotype is associated with frequent recurrence of acute otitis media.
    Emonts M; Wiertsema SP; Veenhoven RH; Houwing-Duistermaat JJ; Walraven V; de Groot R; Hermans PW; Sanders EA
    Pediatrics; 2007 Aug; 120(2):e317-23. PubMed ID: 17671042
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinicopathological significance of plasminogen activator inhibitor-1 promoter 4G/5G polymorphism in breast cancer: a meta-analysis.
    Lee JH; Kim Y; Choi JW; Kim YS
    Arch Med Res; 2013 Jan; 44(1):39-45. PubMed ID: 23291383
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of -675 4G/5G PAI-1 and -2518A/G MCP-1 genetic polymorphisms with polycystic ovary syndrome in Kashmiri women: A case control study.
    Yousuf SD; Ganie MA; Mudassar S; Shafi H; Ibrahim S; Jeelani H; Rashid G; Zargar MA; Rashid F
    J Family Med Prim Care; 2022 Aug; 11(8):4743-4752. PubMed ID: 36352998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study of the possible association of plasminogen activator inhibitor type 1 4G/5G insertion/deletion polymorphism with susceptibility to schizophrenia and in its subtypes.
    Yenilmez C; Ozdemir Koroglu Z; Kurt H; Yanas M; Colak E; Degirmenci I; Gunes HV
    J Clin Pharm Ther; 2017 Feb; 42(1):103-107. PubMed ID: 27796029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An interleukin-6 gene promoter polymorphism is associated with polycystic ovary syndrome in South Indian women.
    Tumu VR; Govatati S; Guruvaiah P; Deenadayal M; Shivaji S; Bhanoori M
    J Assist Reprod Genet; 2013 Dec; 30(12):1541-6. PubMed ID: 24114630
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The plasminogen activator inhibitor (PAI-1) 4G/5G promoter polymorphism and PAI-1 levels in ischemic stroke. A case-control study.
    van Goor ML; Gómez García E; Leebeek F; Brouwers GJ; Koudstaal P; Dippel D
    Thromb Haemost; 2005 Jan; 93(1):92-6. PubMed ID: 15630497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of Plasminogen Activator Inhibitor-1 (PAI-1) 4G/5G promoter polymorphism in Indian venous thrombosis patients: A case-control study.
    Prabhudesai A; Shetty S; Ghosh K; Kulkarni B
    Eur J Haematol; 2017 Sep; 99(3):249-254. PubMed ID: 28561456
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of polymorphisms of interleukin-18 gene promoter region with polycystic ovary syndrome in chinese population.
    Yang Y; Qiao J; Li MZ
    Reprod Biol Endocrinol; 2010 Oct; 8():125. PubMed ID: 20964873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4G/5G promoter polymorphism of plasminogen activator inhibitor-1, lipid profiles, and ischemic stroke.
    Chen CH; Eng HL; Chang CJ; Tsai TT; Lai ML; Chen HY; Liu CJ; Lin TM
    J Lab Clin Med; 2003 Aug; 142(2):100-5. PubMed ID: 12960956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasminogen activator inhibitor 1 4G/5G and -844G/A variants in idiopathic recurrent pregnancy loss.
    Magdoud K; Herbepin VG; Touraine R; Almawi WY; Mahjoub T
    Am J Reprod Immunol; 2013 Sep; 70(3):246-52. PubMed ID: 23521508
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasminogen activator inhibitor-1 4G/5G polymorphism and susceptibility to endometriosis in the Italian population.
    Gentilini D; Vigano P; Castaldi D; Mari D; Busacca M; Vercellini P; Somigliana E; di Blasio AM
    Eur J Obstet Gynecol Reprod Biol; 2009 Oct; 146(2):219-21. PubMed ID: 19608328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Luteinizing hormone and LH receptor gene polymorphism with susceptibility of Polycystic ovary syndrome.
    Deswal R; Nanda S; Dang AS
    Syst Biol Reprod Med; 2019 Oct; 65(5):400-408. PubMed ID: 30958034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.